Dose A

BIOLOGICAL2 trials

Sponsors

Cytori Therapeutics, Moonlight Therapeutics, Inc.

Conditions

Acute Myocardial InfarctionPeanut Allergy

Phase 1

Safety of MOON101 for the Treatment of Peanut Allergy

RecruitingNCT07580898

Moonlight Therapeutics, Inc.Peanut Allergy

Start: 2026-06-29End: 2027-12-31Target: 40Updated: 2026-07-14

Phase 2

Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI)

CompletedNCT01216995

Cytori TherapeuticsAcute Myocardial Infarction

Start: 2012-09-30End: 2014-05-31Updated: 2014-11-21